- Home
- BGB
BGB
Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest
as 12-18-2024 1:32pm EST
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 154.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $10.40 - $11.97 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest News
BGB Breaking Stock News: Dive into BGB Ticker-Specific Updates for Smart Investing
PR Newswire
5 days ago
Blackstone Credit & Insurance Closed-End Funds Declare Monthly Distributions
PR Newswire
a month ago
Blackstone Credit & Insurance Closed-End Funds Announce Trustee, Officer, and Portfolio Management Team Changes
CoinDesk
2 months ago
Bitget Token Tumbles 52% on 'Market Sluggishness,' Exchange Says, While Promising Compensation
PR Newswire
3 months ago
Blackstone Credit & Insurance Closed-End Funds Declare Monthly Distributions
PR Newswire
6 months ago
Blackstone Credit & Insurance Closed-End Funds Announce Corrected Ex-Dividend Dates for Monthly Distributions
PR Newswire
6 months ago
Blackstone Credit & Insurance Closed-End Funds Declare Monthly Distributions
Yahoo Finance Video
6 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
GlobeNewswire
6 months ago
Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis
Compare BGB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BGB Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.